tirzepatide slows gastric emptying vs. Gastroparesis Side Effects: What to Know Tirzepatide Mounjaro Slows Gastric Emptying

The optimistic scenario assumes: Higher weight-loss efficacy, based on emerging data from trials of AOMs Expanded access to the drug, driving higher uptake assumptions Higher persistency, driven by reduced costs and oral forms of the drug and fewer side effects Lower weight regain after stopping the drug Higher non-weight-loss-related mortality impacts The pessimistic scenario, conversely, considers lower efficacy, lower uptake assumptions, higher and quicker weight regain, and lower non-weight-loss-related mortality impacts

The studies also found that one in three participants taking Zepbound at the highest dose lost over 58 lbs or 25% of their body weight

Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ

Linong Ji: No competing interests

Several forces will shape this trajectory: Patent Expiry and Pricing: Semaglutides Loss of Exclusivity Off-patent semaglutide will be a defining event in 2026 as it begins to come off patent in several countries